SG3 Management’s Amgen AMGN Stock Holding History

SG3 Management’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-124,500	Closed	-$28M	–	937
2021 Q4	$28M	Buy	124,500 +52,000	+72%	+$11M	0.57%	24
2021 Q3	$15.4M	Sell	72,500 -12,500	-15%	-$2.88M	0.47%	32
2021 Q2	$20.7M	Buy	85,000 +3,500	+4%	+$861K	0.74%	22
2021 Q1	$20.3M	Buy	81,500 +77,500	+1,938%	+$18.5M	0.51%	27
2020 Q4	$920K	Hold	4,000	–	–	0.02%	585
2020 Q3	$1.02M	Buy	+4,000	New	+$991K	0.04%	419
2020 Q1	–	Sell	-4,000	Closed	-$964K	–	349
2019 Q4	$964K	Hold	4,000	–	–	0.06%	108
2019 Q3	$774K	Hold	4,000	–	–	0.07%	153
2019 Q2	$737K	Buy	+4,000	New	+$716K	0.08%	184
2018 Q2	–	Sell	-25,000	Closed	-$4.26M	–	112
2018 Q1	$4.26M	Buy	+25,000	New	+$4.59M	1.75%	13
2017 Q3	–	Sell	-20,000	Closed	-$3.44M	–	173
2017 Q2	$3.44M	Buy	+20,000	New	+$3.25M	0.86%	33

Other funds holding AMGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

SG3 Management's AMGN Position: Q1 2022 in Review

SG3 Management sold out of Amgen (AMGN) in Q1 2022, closing a stake of 48,000 shares — an estimated $10.8M sold.

SG3 Management first reported a position in AMGN in Q2 2017 and held it in 3 quarters. The position peaked at $10.8M in Q4 2021. 2,337 funds tracked by Wall St. Rank hold AMGN as of Q1 2022.

SG3 Management reported no remaining Amgen position as of Q1 2022 after selling out during the quarter.
SG3 Management sold 48,000 Amgen shares in Q1 2022, an estimated $10.8M.
SG3 Management first reported a position in Amgen in Q2 2017 and held it in 3 quarters.
SG3 Management's Amgen position peaked at $10.8M in Q4 2021.
2,337 funds tracked by Wall St. Rank held Amgen as of Q1 2022.

Based on SG3 Management's 13F filing for Q1 2022, filed 16 May 2022.